Katie Binley

1.0k total citations
22 papers, 784 citations indexed

About

Katie Binley is a scholar working on Molecular Biology, Genetics and Ophthalmology. According to data from OpenAlex, Katie Binley has authored 22 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Genetics and 5 papers in Ophthalmology. Recurrent topics in Katie Binley's work include Virus-based gene therapy research (6 papers), Retinal Development and Disorders (5 papers) and Retinal Diseases and Treatments (4 papers). Katie Binley is often cited by papers focused on Virus-based gene therapy research (6 papers), Retinal Development and Disorders (5 papers) and Retinal Diseases and Treatments (4 papers). Katie Binley collaborates with scholars based in United Kingdom, United States and France. Katie Binley's co-authors include Peter E. Sudbery, Rory Care, Stuart Naylor, Sharifah Iqball, Simon Naylor, Jonathan White, Marie Craigon, R. Adron Harris, Toby Price and Kyriacos Mitrophanous and has published in prestigious journals such as The Lancet, Blood and PLoS ONE.

In The Last Decade

Katie Binley

20 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katie Binley United Kingdom 13 559 179 147 127 92 22 784
Haiqing Yi United States 19 533 1.0× 28 0.2× 174 1.2× 73 0.6× 62 0.7× 34 851
Brenda Brankin United Kingdom 14 229 0.4× 46 0.3× 40 0.3× 93 0.7× 37 0.4× 24 569
Monika Anand United States 12 541 1.0× 26 0.1× 41 0.3× 58 0.5× 98 1.1× 14 705
Janett Schwarz Germany 8 717 1.3× 62 0.3× 88 0.6× 52 0.4× 34 0.4× 9 963
Heide Plesken United States 9 701 1.3× 19 0.1× 104 0.7× 143 1.1× 43 0.5× 9 1.0k
Cari A. Sagum United States 18 836 1.5× 145 0.8× 164 1.1× 103 0.8× 10 0.1× 29 1.1k
Sabine Suppmann Germany 10 417 0.7× 16 0.1× 52 0.4× 41 0.3× 116 1.3× 15 636
Daqian Sun United States 14 499 0.9× 49 0.3× 46 0.3× 28 0.2× 22 0.2× 20 828
Gábor Zahuczky Hungary 13 230 0.4× 45 0.3× 42 0.3× 59 0.5× 14 0.2× 27 569
Michel Roberge Canada 10 420 0.8× 70 0.4× 20 0.1× 300 2.4× 13 0.1× 10 747

Countries citing papers authored by Katie Binley

Since Specialization
Citations

This map shows the geographic impact of Katie Binley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie Binley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie Binley more than expected).

Fields of papers citing papers by Katie Binley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie Binley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie Binley. The network helps show where Katie Binley may publish in the future.

Co-authorship network of co-authors of Katie Binley

This figure shows the co-authorship network connecting the top 25 collaborators of Katie Binley. A scholar is included among the top collaborators of Katie Binley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie Binley. Katie Binley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Badin, Romina Aron, Katie Binley, Nadja Van Camp, et al.. (2019). Gene Therapy for Parkinson’s Disease: Preclinical Evaluation of Optimally Configured TH:CH1 Fusion for Maximal Dopamine Synthesis. Molecular Therapy — Methods & Clinical Development. 14. 206–216. 19 indexed citations
2.
Parker, Maria A., Katie Binley, Julie Loader, et al.. (2018). Safety and Efficacy of OXB-202, a Genetically Engineered Tissue Therapy for the Prevention of Rejection in High-Risk Corneal Transplant Patients. Human Gene Therapy. 29(6). 687–698. 10 indexed citations
3.
Ng, Wai Siene, Katie Binley, Bing Song, & James P. Morgan. (2015). Use of magnetic nanoparticles and oscillating magnetic field for non-viral gene transfer into mouse cornea. The Lancet. 385. S75–S75. 7 indexed citations
4.
Badin, Romina Aron, Katie Binley, Nadja Van Camp, et al.. (2015). 200. Advancing a State of the Art Gene Therapy for Parkinson's Disease. Molecular Therapy. 23. S79–S80.
5.
Zallocchi, Marisa, Katie Binley, Yatish Lad, et al.. (2014). EIAV-Based Retinal Gene Therapy in the shaker1 Mouse Model for Usher Syndrome Type 1B: Development of UshStat. PLoS ONE. 9(4). e94272–e94272. 83 indexed citations
6.
Zallocchi, Marisa, Linda Cheung, You‐Wei Peng, et al.. (2012). Results of Safety and Tolerability Studies of UshStat®, an EIAV-based Lentiviral-vector Therapy for USH1B and the Elucidation of Retinal Cell Types Responsible for USH1B Pathology. Investigative Ophthalmology & Visual Science. 53(14). 1892–1892. 1 indexed citations
7.
Binley, Katie, Peter Widdowson, Michelle Kelleher, et al.. (2012). Safety and Biodistribution of an Equine Infectious Anemia Virus-Based Gene Therapy, RetinoStat ® , for Age-Related Macular Degeneration. Human Gene Therapy. 23(9). 980–991. 48 indexed citations
8.
Ellis, Scott, et al.. (2012). Assessment of Integration-defective HIV-1 and EIAV Vectors In Vitro and In Vivo. Molecular Therapy — Nucleic Acids. 1. e60–e60. 1 indexed citations
10.
Binley, Katie, Sharifah Iqball, T. Michael Nork, et al.. (2008). Evaluation of EIAV Based Lentiviral Vectors Following Ocular Delivery in the Nonhuman Primate Model: Development of RetinoStat®. Investigative Ophthalmology & Visual Science. 49(13). 5340–5340. 1 indexed citations
11.
Kachi, Shu, Katie Binley, Katsutoshi Yokoi, et al.. (2008). EIAV vector-mediated co-delivery of Endostatin and Angiostatin driven by the RPE-specific VMD2 Promoter Inhibits Choroidal Neovascularization. Human Gene Therapy. 0(ja). 3420089880–3420089880. 4 indexed citations
12.
Kong, Jian, Sharifah Iqball, O. Kan, et al.. (2007). Development of photoreceptor‐specific promoters and their utility to investigate EIAV lentiviral vector mediated gene transfer to photoreceptors. The Journal of Gene Medicine. 9(12). 1015–1023. 19 indexed citations
15.
White, Jonathan, R. Adron Harris, Marie Craigon, et al.. (2003). Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis. Genomics. 83(1). 1–8. 112 indexed citations
16.
Binley, Katie, et al.. (2003). Exploiting the hypoxia response.. PubMed. 5(6). 650–6. 10 indexed citations
17.
Binley, Katie, Sharifah Iqball, Hayley Spearman, et al.. (2002). Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy. Blood. 100(7). 2406–2413. 74 indexed citations
19.
Care, Rory, et al.. (1999). The MET3 promoter: a new tool for Candida albicans molecular genetics. Molecular Microbiology. 34(4). 792–798. 223 indexed citations
20.
Radcliffe, P. A., et al.. (1997). >Filamentous growth of the budding yeast Saccharomyces cerevisiae induced by overexpression of the WH12 gene. Microbiology. 143(6). 1867–1876. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026